VITULLO NICOLE

10% owner at Vanda Pharmaceuticals Inc. · on record since Apr 18, 2006
10% owner at VERACYTE, INC. · on record since Oct 29, 2013
10% owner at Paratek Pharmaceuticals, Inc. · on record since May 9, 2006
10% owner at Northstar Neuroscience, Inc. · on record since May 4, 2006
10% owner at Pernix Sleep, Inc. · on record since Sep 20, 2006
10% owner at CADENCE PHARMACEUTICALS INC · on record since Oct 30, 2006
10% owner at Volcano Corp · on record since Jun 14, 2007
10% owner at Orexigen Therapeutics, Inc. · on record since Nov 29, 2007
10% owner at NUVASIVE INC · on record since May 12, 2004
10% owner at Clovis Oncology, Inc. · on record since Nov 21, 2011
10% owner at ALIMERA SCIENCES INC · on record since Apr 27, 2010
10% owner at ACHILLION PHARMACEUTICALS INC · on record since Aug 23, 2010
10% owner at TANDEM DIABETES CARE INC · on record since Nov 19, 2013
10% owner at ZOGENIX, INC. · on record since Nov 22, 2010
Director at ACHILLION PHARMACEUTICALS INC · on record since Dec 20, 2010
Director at Durata Therapeutics, Inc. · on record since Jul 24, 2012
10% owner at Durata Therapeutics, Inc. · on record since Jul 24, 2012
Director at Celator Pharmaceuticals Inc · on record since Jan 15, 2013
10% owner at · on record since Jan 15, 2013
Director at · on record since Jun 25, 2013
10% owner at · on record since Jun 25, 2013
10% owner at · on record since Jul 31, 2013
10% owner at · on record since Sep 30, 2013
10% owner at · on record since Aug 28, 2013
10% owner at · on record since Jan 29, 2014
10% owner at · on record since Mar 17, 2014
Director at · on record since Feb 9, 2004
10% owner at · on record since May 7, 2014
Director at · on record since Jul 31, 2014
10% owner at · on record since Jul 31, 2014
10% owner at · on record since Aug 18, 2014
10% owner at · on record since Oct 14, 2016
10% owner at · on record since Nov 26, 2014
10% owner at · on record since Oct 21, 2014
10% owner at · on record since Jun 24, 2015
10% owner at · on record since May 12, 2015
10% owner at · on record since May 11, 2015
10% owner at · on record since Mar 8, 2016
10% owner at · on record since Aug 27, 2018
10% owner at · on record since May 13, 2019

Insider trading activity of VITULLO NICOLE

Transactions on record: 401; since Feb 9, 2004

Open-market buys: 57; $101.8M

Open-market sells: 49; $12.6M

Companies traded: 25; last filing Jun 2, 2025

Figures computed from official regulatory filings — .

Companies where VITULLO NICOLE has traded

47 tx · $7M · Jun 2, 2025
23 tx · $67.4K · Feb 7, 2022
53 tx · $45.3M · Jan 29, 2020
8 tx · $11.5K · Aug 27, 2018
16 tx · $11.1M · Nov 3, 2016
16 tx · $72.6M · Jul 12, 2016
1 tx · $1M · May 2, 2016
9 tx · $222.8K · Apr 27, 2016
3 tx · Jul 1, 2015
12 tx · $5.4M · Dec 10, 2014
8 tx · $7.1M · Nov 18, 2014
39 tx · $181.8M · Mar 21, 2014
8 tx · Mar 17, 2014
10 tx · Feb 4, 2014

Track record of VITULLO NICOLE

Statistical track record

Free account

Open-market buys: 61

Last buy: Nov 25, 2014

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of VITULLO NICOLE

Co-insiders of VITULLO NICOLE

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Esperion Therapeutics, Inc.Security delisted	Jun 2, 2025	AwardD (derivative)	88,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 24, 2024	AwardD (derivative)	65,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	Jun 16, 2023	AwardD (derivative)	21,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	Jun 16, 2023	Award	5,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 27, 2022	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Feb 7, 2022	Award	2,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Feb 7, 2022	AwardD (derivative)	12,375	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 28, 2021	Award	12,376	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	-619,221	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	-11,612	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Sell	-4,250	15.87 USD	$67.4K	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	-6,192	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	2,717	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	6,192	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Jan 20, 2021	AwardD (derivative)	16,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Nov 6, 2020	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 29, 2020	Award	6,106	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	Other	-25,159	6.30 USD	$158.5K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-50,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	Other	-36,431	6.30 USD	$229.5K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Esperion Therapeutics, Inc.Security delisted	Jun 2, 2025	AwardD (derivative)	88,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 24, 2024	AwardD (derivative)	65,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	Jun 16, 2023	AwardD (derivative)	21,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	Jun 16, 2023	Award	5,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 27, 2022	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Feb 7, 2022	Award	2,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Feb 7, 2022	AwardD (derivative)	12,375	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 28, 2021	Award	12,376	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	-619,221	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	-11,612	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Sell	-4,250	15.87 USD	$67.4K	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	-6,192	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	2,717	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Mar 16, 2021	Other	6,192	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Jan 20, 2021	AwardD (derivative)	16,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
MARINUS PHARMACEUTICALS, INC.Listing unverified	Nov 6, 2020	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Esperion Therapeutics, Inc.Security delisted	May 29, 2020	Award	6,106	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	Other	-25,159	6.30 USD	$158.5K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-50,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	Other	-36,431	6.30 USD	$229.5K	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
ACHILLION PHARMACEUTICALS INCListing unverified	Jan 29, 2020	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)	SEC